Jeffrey Michael Sobell MD
Associate Professor, Dermatology, Tufts Medical Center
Join to view full profile
736 Cambridge St.Brighton, MA 02135
Dr. Sobell is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jeffrey Sobell is a dermatologist in Chestnut Hill, MA and is affiliated with multiple hospitals in the area, including Tufts Medical Center, New England Baptist Hospital, and MelroseWakefield Healthcare. He received his medical degree from University of Virginia School of Medicine and has been in practice 24 years. He is experienced in general dermatology, psoriasis, blistering diseases, and complex medical dermatology. He has more than 20 publications and over 500 citings.
Education & Training
Boston University Medical CenterResidency, Dermatology, 1994 - 1997
University of Virginia Medical CenterInternship, Internal Medicine, 1993 - 1994
University of Virginia School of MedicineClass of 1993
Certifications & Licensure
MA State Medical License 1997 - 2027
American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification SRS EHR, SRS-Health, 2013-2015
- Boston Magazine Castle Connolly, 2010-2013
- Fellow (FAAD) American Academy of Dermatology
Publications & Presentations
PubMed
- Response to "Elevated risk of active tuberculosis with interleukin (IL)-17, IL-23, IL-12/23, Janus kinase inhibitors, cyclosporine, and tumor necrosis factor-α inhibit...Harrison P Nguyen, Eingun James Song, Edward Ted Lain, Jeffrey M Sobell, Linda Stein-Gold
Journal of the American Academy of Dermatology. 2026-08-01 - Clinical Considerations for the Use of Biologic Agents in Psoriasis Patients With a History of Lymphoma.Allison Bai, Emily Gartrell, Olivia Whittaker, Jeffrey Sobell
Journal of Psoriasis and Psoriatic Arthritis. 2025-10-23 - 3 citationsDeucravacitinib: Adverse Events of Interest Across Phase 3 Plaque Psoriasis Trials.Joseph F Merola, Laura K Ferris, Jeffrey M Sobell, Howard Sofen, John Osborne
Dermatology and Therapy. 2025-02-01
Press Mentions
Pearls to Optimize Safety, Success with BiologicsDecember 5th, 2016
OTEZLA® (Apremilast) Mantiene El Perfil De Seguridad a Largo Plazo en El Tratamiento De Psoriasis Y Artritis Psoriásica, Según Nuevos DatosMarch 11th, 2016- Oral OTEZLA® (Apremilast) Long-Term Safety Data Presented at American Academy of Dermatology CongressMarch 7th, 2016
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: